nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—GRK7—eye—age related macular degeneration	0.0268	0.0903	CbGeAlD
Ruxolitinib—GRK7—retina—age related macular degeneration	0.0266	0.0895	CbGeAlD
Ruxolitinib—GRK1—eye—age related macular degeneration	0.0194	0.0653	CbGeAlD
Ruxolitinib—GRK1—retina—age related macular degeneration	0.0192	0.0647	CbGeAlD
Ruxolitinib—CAMK1D—eye—age related macular degeneration	0.0114	0.0384	CbGeAlD
Ruxolitinib—JAK3—connective tissue—age related macular degeneration	0.0113	0.0381	CbGeAlD
Ruxolitinib—CAMK1D—retina—age related macular degeneration	0.0113	0.038	CbGeAlD
Ruxolitinib—JAK1—connective tissue—age related macular degeneration	0.0112	0.0379	CbGeAlD
Ruxolitinib—HIPK2—connective tissue—age related macular degeneration	0.0105	0.0354	CbGeAlD
Ruxolitinib—ROCK1—eye—age related macular degeneration	0.01	0.0339	CbGeAlD
Ruxolitinib—ROCK1—retina—age related macular degeneration	0.00996	0.0335	CbGeAlD
Ruxolitinib—ROCK1—connective tissue—age related macular degeneration	0.00968	0.0326	CbGeAlD
Ruxolitinib—BMPR2—connective tissue—age related macular degeneration	0.0094	0.0317	CbGeAlD
Ruxolitinib—CAMK2G—eye—age related macular degeneration	0.00873	0.0294	CbGeAlD
Ruxolitinib—BMP2K—connective tissue—age related macular degeneration	0.00842	0.0284	CbGeAlD
Ruxolitinib—MAP3K7—retina—age related macular degeneration	0.00779	0.0262	CbGeAlD
Ruxolitinib—TYK2—eye—age related macular degeneration	0.00772	0.026	CbGeAlD
Ruxolitinib—TYK2—retina—age related macular degeneration	0.00765	0.0258	CbGeAlD
Ruxolitinib—MAP3K2—connective tissue—age related macular degeneration	0.00764	0.0257	CbGeAlD
Ruxolitinib—MKNK2—eye—age related macular degeneration	0.00762	0.0257	CbGeAlD
Ruxolitinib—MKNK2—retina—age related macular degeneration	0.00755	0.0254	CbGeAlD
Ruxolitinib—TYK2—connective tissue—age related macular degeneration	0.00743	0.025	CbGeAlD
Ruxolitinib—MKNK2—connective tissue—age related macular degeneration	0.00734	0.0247	CbGeAlD
Ruxolitinib—RET—connective tissue—age related macular degeneration	0.00716	0.0241	CbGeAlD
Ruxolitinib—JAK2—connective tissue—age related macular degeneration	0.00676	0.0228	CbGeAlD
Ruxolitinib—TAOK3—eye—age related macular degeneration	0.00617	0.0208	CbGeAlD
Ruxolitinib—TAOK3—retina—age related macular degeneration	0.00611	0.0206	CbGeAlD
Ruxolitinib—TAOK3—connective tissue—age related macular degeneration	0.00594	0.02	CbGeAlD
Ruxolitinib—TYK2—Signaling by VEGF—VEGFA—age related macular degeneration	0.000281	0.000399	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—ABCA4—age related macular degeneration	0.000279	0.000396	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—RPE65—age related macular degeneration	0.000276	0.000393	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—C2—age related macular degeneration	0.000275	0.000391	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—ABCA4—age related macular degeneration	0.000274	0.00039	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—CRP—age related macular degeneration	0.000273	0.000388	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—TGFBR1—age related macular degeneration	0.000268	0.000381	CbGpPWpGaD
Ruxolitinib—JAK2—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.000265	0.000377	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—RPE65—age related macular degeneration	0.000263	0.000374	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—SQSTM1—age related macular degeneration	0.000263	0.000374	CbGpPWpGaD
Ruxolitinib—JAK3—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000262	0.000373	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—SQSTM1—age related macular degeneration	0.000262	0.000372	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—TLR4—age related macular degeneration	0.000261	0.000372	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CFI—age related macular degeneration	0.000259	0.000369	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—RHO—age related macular degeneration	0.000256	0.000363	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—RPE65—age related macular degeneration	0.000255	0.000363	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—RHO—age related macular degeneration	0.000253	0.00036	CbGpPWpGaD
Ruxolitinib—ROCK1—Focal Adhesion—VEGFA—age related macular degeneration	0.00025	0.000356	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—CD36—age related macular degeneration	0.000249	0.000354	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—RPE65—age related macular degeneration	0.000248	0.000352	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—CD36—age related macular degeneration	0.000247	0.000351	CbGpPWpGaD
Ruxolitinib—CAMK2G—Cellular responses to stress—VEGFA—age related macular degeneration	0.000247	0.000351	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—CD36—age related macular degeneration	0.000245	0.000348	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—APOE—age related macular degeneration	0.000244	0.000348	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CFH—age related macular degeneration	0.000244	0.000347	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—CD36—age related macular degeneration	0.000244	0.000347	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—RHO—age related macular degeneration	0.000242	0.000345	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CFHR3—age related macular degeneration	0.000241	0.000343	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—SQSTM1—age related macular degeneration	0.000241	0.000342	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—RHO—age related macular degeneration	0.000238	0.000339	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CFH—age related macular degeneration	0.000237	0.000337	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CFB—age related macular degeneration	0.000237	0.000337	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—SQSTM1—age related macular degeneration	0.000235	0.000334	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CFH—age related macular degeneration	0.00023	0.000327	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CFB—age related macular degeneration	0.00023	0.000327	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—RHO—age related macular degeneration	0.00023	0.000326	CbGpPWpGaD
Ruxolitinib—JAK1—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000225	0.00032	CbGpPWpGaD
Ruxolitinib—JAK2—VEGFA-VEGFR2 Pathway—VEGFA—age related macular degeneration	0.000225	0.00032	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CFB—age related macular degeneration	0.000223	0.000317	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—ABCA4—age related macular degeneration	0.000223	0.000317	CbGpPWpGaD
Ruxolitinib—TYK2—Axon guidance—KDR—age related macular degeneration	0.000222	0.000316	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—SQSTM1—age related macular degeneration	0.000222	0.000315	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—RDH8—age related macular degeneration	0.000221	0.000315	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—APOE—age related macular degeneration	0.000221	0.000314	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—CD36—age related macular degeneration	0.00022	0.000312	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—APOE—age related macular degeneration	0.000218	0.00031	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—CST3—age related macular degeneration	0.000216	0.000308	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—KDR—age related macular degeneration	0.000215	0.000306	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—C2—age related macular degeneration	0.000215	0.000306	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by VEGF—VEGFA—age related macular degeneration	0.000213	0.000302	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—ABCA4—age related macular degeneration	0.000212	0.000301	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—KDR—age related macular degeneration	0.000211	0.000301	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—CD36—age related macular degeneration	0.00021	0.000298	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—C3—age related macular degeneration	0.000208	0.000296	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—ABCA4—age related macular degeneration	0.000206	0.000293	CbGpPWpGaD
Ruxolitinib—PRKCE—GPCR downstream signaling—C3—age related macular degeneration	0.000201	0.000286	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—ABCA4—age related macular degeneration	0.0002	0.000284	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—CRP—age related macular degeneration	0.000198	0.000282	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—C3—age related macular degeneration	0.000196	0.000278	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—TGFBR1—age related macular degeneration	0.000194	0.000276	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—RHO—age related macular degeneration	0.000194	0.000275	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—RPE65—age related macular degeneration	0.000193	0.000275	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—SQSTM1—age related macular degeneration	0.000191	0.000271	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—TLR4—age related macular degeneration	0.00019	0.00027	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—TGFBR1—age related macular degeneration	0.000187	0.000267	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—APOE—age related macular degeneration	0.000185	0.000263	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—RHO—age related macular degeneration	0.000184	0.000262	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—C3—age related macular degeneration	0.000184	0.000261	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—CD36—age related macular degeneration	0.000184	0.000261	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—C3—age related macular degeneration	0.000183	0.00026	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—APOE—age related macular degeneration	0.000182	0.000259	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CFH—age related macular degeneration	0.00018	0.000256	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—RHO—age related macular degeneration	0.000179	0.000254	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—KDR—age related macular degeneration	0.000178	0.000254	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—CD36—age related macular degeneration	0.000176	0.000251	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CFB—age related macular degeneration	0.000174	0.000248	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—RHO—age related macular degeneration	0.000174	0.000247	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—APOE—age related macular degeneration	0.000171	0.000243	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—SQSTM1—age related macular degeneration	0.00017	0.000242	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—C3—age related macular degeneration	0.00017	0.000242	CbGpPWpGaD
Ruxolitinib—JAK2—Axon guidance—KDR—age related macular degeneration	0.000169	0.00024	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—KDR—age related macular degeneration	0.000168	0.000238	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—CD36—age related macular degeneration	0.000167	0.000238	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—C3—age related macular degeneration	0.000167	0.000237	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—C3—age related macular degeneration	0.000166	0.000236	CbGpPWpGaD
Ruxolitinib—JAK1—Axon guidance—VEGFA—age related macular degeneration	0.000166	0.000236	CbGpPWpGaD
Ruxolitinib—ROCK1—Axon guidance—VEGFA—age related macular degeneration	0.000163	0.000232	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—CD36—age related macular degeneration	0.000162	0.000231	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—CD36—age related macular degeneration	0.000161	0.00023	CbGpPWpGaD
Ruxolitinib—PRKCE—Hemostasis—VEGFA—age related macular degeneration	0.00016	0.000228	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—CST3—age related macular degeneration	0.00016	0.000227	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—CRP—age related macular degeneration	0.000159	0.000226	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—KDR—age related macular degeneration	0.000159	0.000226	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—C3—age related macular degeneration	0.000158	0.000225	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TGFBR1—age related macular degeneration	0.000158	0.000225	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—CD36—age related macular degeneration	0.000158	0.000224	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—CD36—age related macular degeneration	0.000157	0.000224	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—ABCA4—age related macular degeneration	0.000156	0.000222	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—APOE—age related macular degeneration	0.000155	0.00022	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—C3—age related macular degeneration	0.000154	0.000219	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—C3—age related macular degeneration	0.000154	0.000219	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—CCL2—age related macular degeneration	0.000153	0.000218	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—C3—age related macular degeneration	0.000153	0.000217	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—TLR4—age related macular degeneration	0.000152	0.000217	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—KDR—age related macular degeneration	0.000152	0.000216	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—CD36—age related macular degeneration	0.000151	0.000215	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—CRP—age related macular degeneration	0.000151	0.000214	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—C3—age related macular degeneration	0.000149	0.000212	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—C3—age related macular degeneration	0.000149	0.000212	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—CD36—age related macular degeneration	0.000149	0.000211	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—CRP—age related macular degeneration	0.000146	0.000208	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—C3—age related macular degeneration	0.000146	0.000208	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—CRP—age related macular degeneration	0.000145	0.000207	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—SQSTM1—age related macular degeneration	0.000145	0.000206	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—TLR4—age related macular degeneration	0.000144	0.000205	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—CCL2—age related macular degeneration	0.000144	0.000205	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—C3—age related macular degeneration	0.000144	0.000204	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—APOE—age related macular degeneration	0.000144	0.000204	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—TGFBR1—age related macular degeneration	0.000143	0.000204	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—SQSTM1—age related macular degeneration	0.000143	0.000204	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—C3—age related macular degeneration	0.000143	0.000204	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—CCL2—age related macular degeneration	0.000143	0.000203	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—CRP—age related macular degeneration	0.000142	0.000202	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—CRP—age related macular degeneration	0.000142	0.000202	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—C3—age related macular degeneration	0.000141	0.0002	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—SQSTM1—age related macular degeneration	0.000141	0.0002	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—TLR4—age related macular degeneration	0.00014	0.000199	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—TLR4—age related macular degeneration	0.000139	0.000198	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—CD36—age related macular degeneration	0.000139	0.000198	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—SQSTM1—age related macular degeneration	0.000137	0.000194	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—CD36—age related macular degeneration	0.000136	0.000194	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—TLR4—age related macular degeneration	0.000136	0.000194	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000136	0.000194	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—TLR4—age related macular degeneration	0.000136	0.000193	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—RHO—age related macular degeneration	0.000136	0.000193	CbGpPWpGaD
Ruxolitinib—JAK3—Hemostasis—VEGFA—age related macular degeneration	0.000135	0.000192	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—CRP—age related macular degeneration	0.000134	0.000191	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000134	0.00019	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—C3—age related macular degeneration	0.000133	0.000189	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—C3—age related macular degeneration	0.00013	0.000186	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—CCL2—age related macular degeneration	0.00013	0.000185	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—TLR4—age related macular degeneration	0.000129	0.000183	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CD36—age related macular degeneration	0.000128	0.000182	CbGpPWpGaD
Ruxolitinib—JAK2—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000126	0.000179	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000123	0.000175	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—CD36—age related macular degeneration	0.000123	0.000175	CbGpPWpGaD
Ruxolitinib—TYK2—Axon guidance—VEGFA—age related macular degeneration	0.000123	0.000174	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000121	0.000173	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—C3—age related macular degeneration	0.000121	0.000172	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CST3—age related macular degeneration	0.000121	0.000172	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—CCL2—age related macular degeneration	0.000121	0.000172	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—KDR—age related macular degeneration	0.00012	0.000171	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—VEGFA—age related macular degeneration	0.000118	0.000168	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—VEGFA—age related macular degeneration	0.000116	0.000166	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—C3—age related macular degeneration	0.000116	0.000166	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—VEGFA—age related macular degeneration	0.000116	0.000165	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CRP—age related macular degeneration	0.000115	0.000164	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—CRP—age related macular degeneration	0.000111	0.000158	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—TLR4—age related macular degeneration	0.000111	0.000157	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—TGFBR1—age related macular degeneration	0.000109	0.000155	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—C3—age related macular degeneration	0.000108	0.000154	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—SQSTM1—age related macular degeneration	0.000107	0.000152	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—TLR4—age related macular degeneration	0.000106	0.000151	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—APOE—age related macular degeneration	0.000104	0.000148	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—CCL2—age related macular degeneration	0.000104	0.000148	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000103	0.000147	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—CCL2—age related macular degeneration	0.000102	0.000145	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—APOE—age related macular degeneration	0.0001	0.000143	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TGFBR1—age related macular degeneration	0.0001	0.000143	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—KDR—age related macular degeneration	9.85e-05	0.00014	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—VEGFA—age related macular degeneration	9.83e-05	0.00014	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—C3—age related macular degeneration	9.79e-05	0.000139	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TGFBR1—age related macular degeneration	9.74e-05	0.000139	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CD36—age related macular degeneration	9.73e-05	0.000138	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CD36—age related macular degeneration	9.44e-05	0.000134	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—SQSTM1—age related macular degeneration	9.38e-05	0.000133	CbGpPWpGaD
Ruxolitinib—JAK2—Axon guidance—VEGFA—age related macular degeneration	9.28e-05	0.000132	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—VEGFA—age related macular degeneration	9.24e-05	0.000131	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—C3—age related macular degeneration	9.22e-05	0.000131	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CD36—age related macular degeneration	9.16e-05	0.00013	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—C3—age related macular degeneration	9.11e-05	0.00013	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—SQSTM1—age related macular degeneration	9.11e-05	0.00013	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—C3—age related macular degeneration	8.95e-05	0.000127	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—SQSTM1—age related macular degeneration	8.83e-05	0.000126	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CRP—age related macular degeneration	8.77e-05	0.000125	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—VEGFA—age related macular degeneration	8.74e-05	0.000124	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—C3—age related macular degeneration	8.68e-05	0.000123	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CRP—age related macular degeneration	8.51e-05	0.000121	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—APOE—age related macular degeneration	8.48e-05	0.000121	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—CCL2—age related macular degeneration	8.45e-05	0.00012	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—TLR4—age related macular degeneration	8.41e-05	0.00012	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—VEGFA—age related macular degeneration	8.35e-05	0.000119	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—KDR—age related macular degeneration	8.31e-05	0.000118	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CRP—age related macular degeneration	8.26e-05	0.000117	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—C3—age related macular degeneration	8.17e-05	0.000116	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—TLR4—age related macular degeneration	8.16e-05	0.000116	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—TLR4—age related macular degeneration	7.92e-05	0.000113	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—C3—age related macular degeneration	7.84e-05	0.000111	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—C3—age related macular degeneration	7.71e-05	0.00011	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—APOE—age related macular degeneration	7.69e-05	0.000109	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—CCL2—age related macular degeneration	7.66e-05	0.000109	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TGFBR1—age related macular degeneration	7.61e-05	0.000108	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	7.48e-05	0.000106	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—C3—age related macular degeneration	7.42e-05	0.000106	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—APOE—age related macular degeneration	7.3e-05	0.000104	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—APOE—age related macular degeneration	7.18e-05	0.000102	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CD36—age related macular degeneration	7.16e-05	0.000102	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—KDR—age related macular degeneration	7.15e-05	0.000102	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—CCL2—age related macular degeneration	7.13e-05	0.000101	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—KDR—age related macular degeneration	7.03e-05	0.0001	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—SQSTM1—age related macular degeneration	6.9e-05	9.82e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—C3—age related macular degeneration	6.78e-05	9.64e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—VEGFA—age related macular degeneration	6.62e-05	9.42e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	6.54e-05	9.3e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—VEGFA—age related macular degeneration	6.5e-05	9.24e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CRP—age related macular degeneration	6.45e-05	9.18e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—TLR4—age related macular degeneration	6.19e-05	8.8e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CCL2—age related macular degeneration	6.13e-05	8.72e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CCL2—age related macular degeneration	6.03e-05	8.58e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—C3—age related macular degeneration	5.96e-05	8.48e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—APOE—age related macular degeneration	5.83e-05	8.29e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CCL2—age related macular degeneration	5.81e-05	8.26e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—C3—age related macular degeneration	5.79e-05	8.23e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—C3—age related macular degeneration	5.61e-05	7.98e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—APOE—age related macular degeneration	5.55e-05	7.89e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—KDR—age related macular degeneration	5.44e-05	7.73e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—VEGFA—age related macular degeneration	5.42e-05	7.71e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—APOE—age related macular degeneration	5.39e-05	7.66e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—KDR—age related macular degeneration	5.28e-05	7.5e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	5.27e-05	7.49e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—APOE—age related macular degeneration	5.22e-05	7.43e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—KDR—age related macular degeneration	5.12e-05	7.28e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CCL2—age related macular degeneration	4.66e-05	6.63e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—VEGFA—age related macular degeneration	4.58e-05	6.51e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CCL2—age related macular degeneration	4.53e-05	6.44e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CCL2—age related macular degeneration	4.39e-05	6.24e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—C3—age related macular degeneration	4.38e-05	6.24e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—APOE—age related macular degeneration	4.08e-05	5.81e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—KDR—age related macular degeneration	4e-05	5.69e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—VEGFA—age related macular degeneration	3.94e-05	5.6e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—VEGFA—age related macular degeneration	3.87e-05	5.51e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CCL2—age related macular degeneration	3.43e-05	4.88e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—VEGFA—age related macular degeneration	2.99e-05	4.26e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—VEGFA—age related macular degeneration	2.91e-05	4.13e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—VEGFA—age related macular degeneration	2.82e-05	4.01e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—LIPC—age related macular degeneration	2.7e-05	3.84e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CETP—age related macular degeneration	2.6e-05	3.7e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—VEGFA—age related macular degeneration	2.2e-05	3.13e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CD36—age related macular degeneration	1.56e-05	2.22e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—APOE—age related macular degeneration	1.38e-05	1.96e-05	CbGpPWpGaD
